Passkey Therapeutics raised $20 million in seed funding led by Breakout Ventures to advance its new class of therapeutics targeting rare combinations of proteins.
Amount Raised
$20 Million
Round Type
Seed
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Passkey Therapeutics announced it has emerged from stealth with $20 million in seed funding led by Breakout Ventures. The funding will support the development of its Synergistic Multifunctional Therapeutics platform designed to target complex biological challenges.
Quick answer
Passkey Therapeutics raised $20 Million in a Seed round, dated October 22, 2024. Investors: Innovation Endeavors, Bison Ventures, Wireframe Ventures, Alexandria Venture Investments, Grids Capital and Breakout Ventures. Passkey Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Passkey Therapeutics raise?
- Passkey Therapeutics raised $20 Million in a Seed round on October 22, 2024.
- Who invested in Passkey Therapeutics?
- Innovation Endeavors, Bison Ventures, Wireframe Ventures, Alexandria Venture Investments, Grids Capital and Breakout Ventures are named as investors in this round.
- What does Passkey Therapeutics do?
- Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together.
- Where is Passkey Therapeutics based and how big is it?
- Passkey Therapeutics is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Passkey Therapeutics?
- Fundz holds 1 contact at Passkey Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Passkey Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Alveron Pharma raised $5.3M (Seed) on December 6, 2024.
- Nuvig Therapeutics raised $161M (Series B) on December 5, 2024.
- Refoxy Pharmaceuticals raised $9.6M (Seed) on December 4, 2024.
- Orakl Oncology raised $12M (Seed) on December 3, 2024.
- SRTD biotech raised an undisclosed amount (Seed) on December 2, 2024.
- TransCode Therapeutics raised $8M on December 2, 2024.
Who to call at Passkey Therapeutics, and when
A new round usually means Passkey Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Passkey Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Passkey Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Passkey Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Passkey Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Passkey Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.